Mucinous Cancer of the Ovary: Overview and Current Status

被引:84
作者
Babaier, Abdulaziz [1 ]
Ghatage, Prafull [2 ]
机构
[1] King Fahad Specialist Hosp, Dept Gynecol Oncol, Dammam 32253, Saudi Arabia
[2] Tom Baker Canc Clin, Dept Gynecol Oncol, Calgary, AB T2N 4N2, Canada
关键词
mucinous ovarian carcinoma; metastatic mucinous carcinoma; genomic profile; surgery; chemotherapy; targeted therapy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PLACENTAL ALKALINE-PHOSPHATASE; RECURRENT EPITHELIAL OVARIAN; HUMAN CHORIONIC-GONADOTROPIN; HEAVILY PRETREATED PATIENTS; LYMPH-NODE METASTASIS; TERM-FOLLOW-UP; PHASE-III; BORDERLINE TUMORS; INTESTINAL-TYPE;
D O I
10.3390/diagnostics10010052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mucinous ovarian cancer (MOC) is a rare subtype of epithelial ovarian carcinoma (EOC). Whereas all EOC subtypes are addressed in the same way, MOC is a distinct entity. Appreciating the pathological features and genomic profile of MOC may result in the improvement in management and, hence, the prognosis. Distinguishing primary MOC from metastatic mucinous carcinoma can be challenging but is essential. Early-stage MOC carries an excellent prognosis, with advanced disease having a poor outcome. Surgical management plays an essential role in the early stage and in metastatic disease. Chemotherapy is usually administered for stage II MOC and beyond. The standard gynecology protocol is frequently used, but gastrointestinal regimens have also been administered. As MOC is associated with multiple molecular alterations, targeted therapy could be the answer to treat this disease.
引用
收藏
页数:16
相关论文
共 97 条
[1]   OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [J].
Aghajanian, Carol ;
Blank, Stephanie V. ;
Goff, Barbara A. ;
Judson, Patricia L. ;
Teneriello, Michael G. ;
Husain, Amreen ;
Sovak, Mika A. ;
Yi, Jing ;
Nycum, Lawrence R. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2039-2045
[2]   Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience [J].
Alexandre, J. ;
Ray-Coquard, I. ;
Selle, F. ;
Floquet, A. ;
Cottu, P. ;
Weber, B. ;
Falandry, C. ;
Lebrun, D. ;
Pujade-Lauraine, E. .
ANNALS OF ONCOLOGY, 2010, 21 (12) :2377-2381
[3]  
Bang YJ, 2010, LANCET, V376, P1302
[4]   Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma [J].
Bassiouny, Dina ;
Ismiil, Nadia ;
Dube, Valerie ;
Han, Guangming ;
Cesari, Matthew ;
Lu, Fang-I ;
Slodkowska, Elzbieta ;
Parra-Herran, Carlos ;
Chiu, Hak Fai ;
Naeim, Magda ;
Li, Nim ;
Khalifa, Mahmoud ;
Nofech-Mozes, Sharon .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2018, 26 (04) :306-317
[5]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[6]   Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei [J].
Benhaim, Leonor ;
Faron, Matthieu ;
Gelli, Maximiliano ;
Sourrouille, Isabelle ;
Honore, Charles ;
Delhorme, Jean-Baptiste ;
Elias, Dominique ;
Goere, Diane .
SURGICAL ONCOLOGY-OXFORD, 2019, 29 :78-83
[7]   Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients [J].
Bentivegna, Enrica ;
Fruscio, Robert ;
Roussin, Stephanie ;
Ceppi, Lorenzo ;
Satoh, Toyomi ;
Kajiyama, Hiroaki ;
Uzan, Catherine ;
Colombo, Nicoletta ;
Gouy, Sebastien ;
Morice, Philippe .
FERTILITY AND STERILITY, 2015, 104 (05) :1319-1324
[8]   Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management [J].
Brown, Jubilee ;
Frumovitz, Michael .
CURRENT ONCOLOGY REPORTS, 2014, 16 (06)
[9]   Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer [J].
Burger, Robert A. ;
Brady, Mark F. ;
Bookman, Michael A. ;
Fleming, Gini F. ;
Monk, Bradley J. ;
Huang, Helen ;
Mannel, Robert S. ;
Homesley, Howard D. ;
Fowler, Jeffrey ;
Greer, Benjamin E. ;
Boente, Matthew ;
Birrer, Michael J. ;
Liang, Sharon X. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) :2473-2483
[10]   The molecular origin and taxonomy of mucinous ovarian carcinoma [J].
Cheasley, Dane ;
Wakefield, Matthew J. ;
Ryland, Georgina L. ;
Allan, Prue E. ;
Alsop, Kathryn ;
Amarasinghe, Kaushalya C. ;
Ananda, Sumitra ;
Anglesio, Michael S. ;
Au-Yeung, George ;
Bohm, Maret ;
Bowtell, David Dl ;
Brand, Alison ;
Chenevix-Trench, Georgia ;
Christie, Michael ;
Chiew, Yoke-Eng ;
Churchman, Michael ;
DeFazio, Anna ;
Demeo, Renee ;
Dudley, Rhiannon ;
Fairweather, Nicole ;
Fedele, Clare G. ;
Fereday, Sian ;
Fox, Stephen B. ;
Gilks, C. Blake ;
Gourley, Charlie ;
Hacker, Neville F. ;
Hadley, Alison M. ;
Hendley, Joy ;
Ho, Gwo-Yaw ;
Hughes, Siobhan ;
Hunstman, David G. ;
Hunter, Sally M. ;
Jobling, Tom W. ;
Kalli, Kimberly R. ;
Kaufmann, Scott H. ;
Kennedy, Catherine J. ;
Kobel, Martin ;
Le Page, Cecile ;
Li, Jason ;
Lupat, Richard ;
McNally, Orla M. ;
McAlpine, Jessica N. ;
Mes-Masson, Anne-Marie ;
Mileshkin, Linda ;
Provencher, Diane M. ;
Pyman, Jan ;
Rahimi, Kurosh ;
Rowley, Simone M. ;
Salazar, Carolina ;
Samimi, Goli .
NATURE COMMUNICATIONS, 2019, 10 (1)